120 related articles for article (PubMed ID: 8400105)
1. Adenosine and myocardial protection.
Gatell JA; Barner HB; Shevde K
J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):466-80. PubMed ID: 8400105
[No Abstract] [Full Text] [Related]
2. Moving preconditioning from bench to bedside.
Kloner RA
J Am Coll Cardiol; 2006 Jul; 48(1):215-6. PubMed ID: 16814670
[No Abstract] [Full Text] [Related]
3. Acadesine, an adenosine-regulating agent with the potential for widespread indications.
Drew BG; Kingwell BA
Expert Opin Pharmacother; 2008 Aug; 9(12):2137-44. PubMed ID: 18671468
[TBL] [Abstract][Full Text] [Related]
4. Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart.
Galiñanes M; Zhai X; Bullough D; Mullane KM; Hearse DJ
J Thorac Cardiovasc Surg; 1995 Sep; 110(3):752-61. PubMed ID: 7564443
[TBL] [Abstract][Full Text] [Related]
5. Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury.
Mullane K
Cardiovasc Res; 1993 Jan; 27(1):43-7. PubMed ID: 8458030
[TBL] [Abstract][Full Text] [Related]
6. Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine.
Mangano DT; Miao Y; Tudor IC; Dietzel C; ;
J Am Coll Cardiol; 2006 Jul; 48(1):206-14. PubMed ID: 16814669
[TBL] [Abstract][Full Text] [Related]
7. Acadesine: a unique cardioprotective agent for myocardial ischemia.
Nawarskas JJ
Heart Dis; 1999; 1(4):255-60. PubMed ID: 11720632
[TBL] [Abstract][Full Text] [Related]
8. Role of acadesine in clinical myocardial protection.
Alkhulaifi AM; Pugsley WB
Br Heart J; 1995 Apr; 73(4):304-5. PubMed ID: 7756061
[No Abstract] [Full Text] [Related]
9. AICAR inhibits the Na+/H+ exchanger in rat hearts--possible contribution to cardioprotection.
Moopanar TR; Xiao XH; Jiang L; Chen ZP; Kemp BE; Allen DG
Pflugers Arch; 2006 Nov; 453(2):147-56. PubMed ID: 16983558
[TBL] [Abstract][Full Text] [Related]
10. Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial.
Newman MF; Ferguson TB; White JA; Ambrosio G; Koglin J; Nussmeier NA; Pearl RG; Pitt B; Wechsler AS; Weisel RD; Reece TL; Lira A; Harrington RA;
JAMA; 2012 Jul; 308(2):157-64. PubMed ID: 22782417
[TBL] [Abstract][Full Text] [Related]
11. Influence of ribose, adenosine, and "AICAR" on the rate of myocardial adenosine triphosphate synthesis during reperfusion after coronary artery occlusion in the dog.
Mauser M; Hoffmeister HM; Nienaber C; Schaper W
Circ Res; 1985 Feb; 56(2):220-30. PubMed ID: 3918804
[TBL] [Abstract][Full Text] [Related]
12. Adenosine and K(+)-induced Ca2+ loading.
Cheng TO
Ann Thorac Surg; 1997 Aug; 64(2):588-9. PubMed ID: 9262636
[No Abstract] [Full Text] [Related]
13. Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart.
Galiñanes M; Bullough D; Mullane KM; Hearse DJ
Circulation; 1992 Aug; 86(2):589-97. PubMed ID: 1638724
[TBL] [Abstract][Full Text] [Related]
14. Harnessing nature's own cardiac defense mechanism with acadesine, an adenosine regulating agent: importance of the endothelium.
Engler RL
J Card Surg; 1994 May; 9(3 Suppl):482-92. PubMed ID: 8069041
[TBL] [Abstract][Full Text] [Related]
15. Adenosine in myocardial protection in on-pump and off-pump cardiac surgery.
Vinten-Johansen J; Zhao ZQ; Corvera JS; Morris CD; Budde JM; Thourani VH; Guyton RA
Ann Thorac Surg; 2003 Feb; 75(2):S691-9. PubMed ID: 12607714
[TBL] [Abstract][Full Text] [Related]
16. Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat.
Galiñanes M; Mullane KM; Bullough D; Hearse DJ
Circulation; 1992 Aug; 86(2):598-608. PubMed ID: 1638725
[TBL] [Abstract][Full Text] [Related]
17. Failure of AICA riboside to limit infarct size during acute myocardial infarction in rabbits.
Dorion M; Rouleau J; Kingma JG
J Cardiovasc Pharmacol; 1992 Jan; 19(1):69-77. PubMed ID: 1375690
[TBL] [Abstract][Full Text] [Related]
18. Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: a way of protecting rat steatotic livers.
Ben Mosbah I; Massip-Salcedo M; Fernández-Monteiro I; Xaus C; Bartrons R; Boillot O; Roselló-Catafau J; Peralta C
Liver Transpl; 2007 Mar; 13(3):410-25. PubMed ID: 17326058
[TBL] [Abstract][Full Text] [Related]
19. Adenosine and AICA-riboside fail to enhance microvascular endothelial preservation.
Sellke FW; Friedman M; Wang SY; Piana RN; Dai HB; Johnson RG
Ann Thorac Surg; 1994 Jul; 58(1):200-6. PubMed ID: 8037525
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine.
Kurz MA; Bullough DA; Buggé CJ; Mullane KM; Young MA
Eur J Pharmacol; 1997 Mar; 322(2-3):211-20. PubMed ID: 9098689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
